HAMA and HARA Titer in Patients Treated With RFT5-SMPT-dgA
| Patient No. . | Courses . | HAMA/HARA (μg/mL) . | Date . |
|---|---|---|---|
| Level 1 (5 mg/m2) | |||
| 1 | 2 | 0.2/0.7 | C2D10 |
| 2 | 2 | 10.2/37.9 | C2D10 |
| 3 | 2 | 0.26/1.0 | C2D9 |
| Level 2 (10 mg/m2) | |||
| 4 | 1 | 0.00/0.00 | C1D10 |
| 5 | 2 | 0.13/0.74 | C2D8 |
| 6 | 1 | 0.00/0.00 | C1D10 |
| Level 3 (15 mg/m2) | |||
| 7 | 2 | 7,689.6/1,323.7 | C2D9 |
| 8 | 2 | 522.3/165.9 | C2D9 |
| 9 | 2 | 0.00/0.00 | C1D10 |
| 10 | 4 | 0.8/0.00 | C4D8 |
| 11 | 2 | 1,375.0/570.0 | C2D10 |
| 12 | 2 | 129.0/876.8 | C2D9 |
| Level 4 (20 mg/m2) | |||
| 13 | 1 | 0.00/0.00 | C1D9 |
| 14 | 2 | 0.15/0.89 | C2D9 |
| 15 | 2 | 106.0/85.2 | C2D9 |
| Patient No. . | Courses . | HAMA/HARA (μg/mL) . | Date . |
|---|---|---|---|
| Level 1 (5 mg/m2) | |||
| 1 | 2 | 0.2/0.7 | C2D10 |
| 2 | 2 | 10.2/37.9 | C2D10 |
| 3 | 2 | 0.26/1.0 | C2D9 |
| Level 2 (10 mg/m2) | |||
| 4 | 1 | 0.00/0.00 | C1D10 |
| 5 | 2 | 0.13/0.74 | C2D8 |
| 6 | 1 | 0.00/0.00 | C1D10 |
| Level 3 (15 mg/m2) | |||
| 7 | 2 | 7,689.6/1,323.7 | C2D9 |
| 8 | 2 | 522.3/165.9 | C2D9 |
| 9 | 2 | 0.00/0.00 | C1D10 |
| 10 | 4 | 0.8/0.00 | C4D8 |
| 11 | 2 | 1,375.0/570.0 | C2D10 |
| 12 | 2 | 129.0/876.8 | C2D9 |
| Level 4 (20 mg/m2) | |||
| 13 | 1 | 0.00/0.00 | C1D9 |
| 14 | 2 | 0.15/0.89 | C2D9 |
| 15 | 2 | 106.0/85.2 | C2D9 |
The cycle (C) and day (D) on which the indicated concentrations of HAMA or HARA were detected is indicated under date.